Drug Trial Radar · NCT00563485
Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up
Last checked: Nov 20, 2026Latest source record: Jun 16, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
120
Planned (sponsor's estimate)
Start
Oct 2005
Primary completion
Not stated
Study completion Nov 2006
Sponsor
- Lead sponsor
- Hospital Authority, Hong KongGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Nov 26, 2007
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Male only, from 50 years
Summary
As written by the sponsor on the registry.
The purpose of the study is to compare two alpha blockers, terazosin and doxazosin GITS, in achieving a successful TWOC after AUR due to BPH, among Chinese males in Hong Kong, and in delaying or avoiding a TURP.
Conditions
- Prostatic Hyperplasia
- Urinary Retention
Interventions
Doxazosin GITS (Cardura XL)Drug
Terazosin (Hytrin)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Successful rate of Trial Without Catheter (TWOC) at phase 1Time frame: At discharge after TWOC (at the end phase one)
- Late failure of TWOC of, which is defined as recurrent of AUR or the need of invasive therapy among those who are successful in TWOC in phase 1Time frame: From the end of phase one to eight months after successful TWOC (the end of phase 2)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Prince of Wales Hospital
Hong Kong, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.